I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 3 studies | 22% ± 3% | |
| oligodendrocyte | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 3 studies | 22% ± 3% | |
| oligodendrocyte | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 5550.30 | 328 / 328 | 100% | 26.44 | 178 / 178 |
| stomach | 100% | 2272.09 | 359 / 359 | 100% | 31.10 | 286 / 286 |
| esophagus | 100% | 2194.56 | 1444 / 1445 | 100% | 40.75 | 183 / 183 |
| lung | 100% | 2468.01 | 577 / 578 | 100% | 36.02 | 1155 / 1155 |
| intestine | 100% | 2586.78 | 966 / 966 | 100% | 28.62 | 526 / 527 |
| prostate | 100% | 2127.70 | 245 / 245 | 100% | 29.28 | 501 / 502 |
| uterus | 100% | 2132.51 | 170 / 170 | 100% | 31.56 | 458 / 459 |
| ovary | 100% | 1827.89 | 180 / 180 | 100% | 31.49 | 429 / 430 |
| skin | 100% | 3144.94 | 1808 / 1809 | 100% | 52.90 | 471 / 472 |
| breast | 100% | 2167.86 | 459 / 459 | 100% | 38.77 | 1115 / 1118 |
| thymus | 100% | 2113.74 | 653 / 653 | 100% | 25.08 | 603 / 605 |
| brain | 100% | 3311.76 | 2633 / 2642 | 100% | 36.41 | 705 / 705 |
| bladder | 100% | 2543.19 | 21 / 21 | 100% | 29.10 | 502 / 504 |
| kidney | 100% | 2256.75 | 89 / 89 | 100% | 26.32 | 897 / 901 |
| adrenal gland | 100% | 2147.56 | 258 / 258 | 98% | 36.88 | 226 / 230 |
| liver | 96% | 1321.00 | 218 / 226 | 99% | 18.60 | 400 / 406 |
| adipose | 100% | 2059.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 35.35 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.24 | 29 / 29 |
| muscle | 100% | 4808.04 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1876.12 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 27.72 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 17.55 | 1 / 1 |
| blood vessel | 100% | 2958.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 3884.17 | 839 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 55% | 724.58 | 510 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008150 | Biological process | biological_process |
| GO_0160063 | Biological process | multi-pass transmembrane protein insertion into ER membrane |
| GO_0160064 | Cellular component | multi-pass translocon complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0043022 | Molecular function | ribosome binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NOMO1 |
| Protein name | Nodal modulator 1 BOS complex subunit NOMO1 (Nodal modulator 1) (pM5 protein) |
| Synonyms | PM5 |
| Description | FUNCTION: Component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes . The MPT complex takes over after the SEC61 complex: following membrane insertion of the first few transmembrane segments of proteins by the SEC61 complex, the MPT complex occludes the lateral gate of the SEC61 complex to promote insertion of subsequent transmembrane regions . . |
| Accessions | ENST00000619292.4 ENST00000633436.1 A0A0G2JP90 A0A0G2JN29 Q15155 ENST00000287667.12 ENST00000565655.1 ENST00000620839.3 ENST00000620819.2 H3BUC9 |
